Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to TAP block after cesarean section
IRCT20220706055402N5Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine and bupivacaine in postoperative pain (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Visual Analogue Scale. Started Feb 2024; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20220706055402N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220706055402N5.